Database of Patients Undergoing Cardiac Computed Tomographic Angiography (CCTA)at William Beaumont Hospital
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Coronary Syndrome
- Sponsor
- Kavitha Chinnaiyan
- Enrollment
- 10000
- Locations
- 1
- Primary Endpoint
- To establish an overarching database of information containing historical, demographical, clinical, and intermediate and long-term outcome data from all WBH patients undergoing CCTA testing for clinical or scientific reasons.
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of the study is to establish an overarching database of information containing historical, demographical, clinical, and intermediate and long-term outcome data from all William Beaumont Hospital (WBH) patients undergoing Cardiac Computed Tomographic Angiography (CCTA) testing for clinical or scientific reasons.
Detailed Description
The principal goal of his project is to enable the study investigators to organize WBH research activity in the field of CCTA by concentrating data from all the patients who allow use of their data in one organized, audited and securely stored database. It will allow the ability to collect retrospective and prospective data from a number of different clinical systems and securely maintain patient medical record numbers for the reference on future projects as well as identification of patients with multiple studies and multiple follow-ups.
Investigators
Kavitha Chinnaiyan
Director of Cardiovascular Imaging Education
William Beaumont Hospitals
Eligibility Criteria
Inclusion Criteria
- •all retrospective patients who under went a CTA and were granted a waiver of consent
- •all prospective patients CTA patients who gave informed consent.
Exclusion Criteria
- •Non CTA patients
- •Patients who refused participation.
Outcomes
Primary Outcomes
To establish an overarching database of information containing historical, demographical, clinical, and intermediate and long-term outcome data from all WBH patients undergoing CCTA testing for clinical or scientific reasons.
Time Frame: annually for 5 years